Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
Go back to Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi| (NASDAQ: RLYB) | Delayed: 16.38 -0.23 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.61 | 52 Week High | $ | |||
| Open | $16.81 | 52 Week Low | $ | |||
| Day High | $16.81 | P/E | N/A | |||
| Day Low | $16.34 | EPS | $ | |||
| Volume | 8,781 | |||||
